Expression of Calretinin, Marker of Mesothelial Differentiation, in Pancreatic Ductal Adenocarcinoma: A Potential Diagnostic Pitfall
TURKISH JOURNAL OF PATHOLOGY, cilt.37, sa.2, ss.115-120, 2021 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 37 Sayı: 2
- Basım Tarihi: 2021
- Doi Numarası: 10.5146/tjpath.2020.01519
- Dergi Adı: TURKISH JOURNAL OF PATHOLOGY
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.115-120
- Anahtar Kelimeler: Calretinin, Pancreatic ductal adenocarcinoma, Poorly differentiated, Undifferentiated, Mesothelioma, FACTORS PREDICTING RECURRENCE, PERITONEAL CARCINOMATOSIS, HUMAN COLON, D2-40, IMMUNOHISTOCHEMISTRY, UTILITY, MOC-31, RESECTION, SARCOMA, BREAST
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır
Özet
Objective: Pancreatic ductal adenocarcinoma is one of the most common causes of "peritoneal carcinomatosis" and has an insidious growth pattern. Thus, it falls into the differential diagnosis of other peritoneal malignancies including malignant mesothelioma. Recently, we have encountered an undifferentiated pancreatic carcinoma presenting with peritoneal disease and exhibiting immunoreactivity to calretinin, mimicking mesothelioma. In this study, we explored the incidence of calretinin expression in pancreatic ductal adenocarcinoma.